Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Chandra Asri Pacific Tbk. (TPIA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Chandra Asri Pacific Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 24.2K 24h volume), while Chandra Asri Pacific Tbk. trades at Rp1,895 (market cap 165.24T, 79.54M 24h volume). The key difference: Chandra Asri Pacific Tbk. is far larger — about 536.5× Diagnos Laboratorium Utama Tbk.'s market cap, and Chandra Asri Pacific Tbk. is more actively traded (79.54M versus 24.2K). Which is the better fit depends on your goals.
| DGNS | TPIA | |
|---|---|---|
Market Cap | 308B | 165.24T |
Volume | 24.2K | 79.54M |
Lot | 242 | 795.42K |
Turnover | 5.5M | 151.53B |
Average Price | 227.27 | 1,905.1 |
Value | 5.5M | 151.53B |
Indicative Equilibrium Price | 230 | 1,925 |
Indicative Equilibrium Volume | 110 | 9.02K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Chandra Asri Pacific Tbk.
PT Chandra Asri Petrochemical Tbk formerly PT. Tri Polyta Indonesia, Tbk (the Company) was established under the Domestic Capital Investment Law No. 6 year 1968 and Law No. 12 year 1970 by Notarial Deed No. 40 dated November 2, 1984 of Ridwan Suselo, S.H., notary public in Jakarta. The Company is the largest Indonesia producer of polypropyleneresins that are used in the manufacture of a wide range of consumer products.
Read more on TPIA →
